Journal of Neuro-Oncology Award

Journal of Neuro-Oncology Award

AWARDS

Year AANS CNS
2024
Kirit Singh

Summary findings of a surgical window-of-opportunity clinical trial evaluating the PCSK9 inhibitor Evolocumab in patients with glioma
Lisa Wadiura, MD

2023
Shreya Budhiraja

Targeting Retrograde Trafficking Pathways to Overcome Chemoresistance in Glioblastoma
Victoria Clark

RNA Polymerase II Meningioma Mutations Activate Forebrain Neurodevelopmental Pathways
2022
Victor Arrieta-Gonzalez

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma
Elaina Wang

Single-cell RNA-seq Highlights Immune-driven Gender Differences in Glioblastoma
2021

Jia-Shu Chen

Cytolytic Score Correlates With An Immunosuppressive Tumor Microenvironment And Reduced Survival In Medulloblastoma
Anudeep Yekula

TERT promoter mutation analysis for blood-based diagnosis and monitoring of gliomas
2020

Addison Barnett, MS

Sex-Associated Analysis of MGMT Promoter Site Methylation in Newly Diagnosed Glioblastoma
Dorota Lubanska

The Role of Human Endothelial Cells in The Brain Tumour Organoid (BTO) Platform as a Unique Tool in Discovery of Novel Treatment Approaches in Glioblastoma
2019

Christopher Alvarez-Breckenridge

Evidence of CNS Response to Pembrolizumab for Leptomeningeal Carcinomatosis at a Single Cell Resolution
Matthew M. Grabowski

Decreased Circulating Myeloid Derived Suppressor Cells at First Follow-up Predict Favorable Response to Immunotherapy in a Randomized Trial of Nivolumab and Bevacizumab in Recurrent GBM
2018

Bob S. Carter

Evaluation of Durable Response Rate in the Post-Resection Setting and Association with Survival in Patients with Recurrent High Grade Glioma who Received Vocimagene Amiretroprepvec and 5-Fluorocytosine Treatment
Joseph P. Antonios

Non-invasive Monitoring of Immunotherapeutic Responses in Glioblastoma using Novel Imaging Techniques
2017

Doris Wang

Seizure Outcome After Surgical Resection of Insular Glioma
Desmond A. Brown

Small Terminal Deletions/Duplications and Alternative Lengthening of Telomeres are Co-Occur in IDH Mutation Only Gliomas
2016

Arman Jahangiri

From Bench to Bedside: NIH Funding for Neurosurgeons From 1991-2015
Andrew E. Sloan

Phase I Trial of Genetically Modified Hematopoietic Progenitor Cells (HPC) Facilitate Bone Marrow Chemoprotection and Enabling TMZ/O6BG Dose Escalation Resulting in Improved Survival
2015

Fred Lang

Phase I Clinical Trial of Oncolytic Delta-24-RGD (DNX-2401) with Biological Endpoints: Implications for Viro-Immunotherapy
Pascal O. Zinn

Diffusion MRI ADC Mapping of Glioblastoma Edema/Tumor Invasion and Associated Gene Signatures
2014

Manish Aghi

Replicating Retrovirus Toca-511 Delivered Using Convection-enhanced Real-time MRI Guidance for Recurrent Glioblastoma
Seunggu Han

The Effect of Timing of Radiotherapy (RT) in Patients with Newly-diagnosed Glioblastoma Multiforme (GBM) Receiving Temozolomide (TMZ): An Analysis Based on the UCSF Experience
2013

Phiroz Tarapore

Jonsong Wu

2012

Arthur Po-Fei Chou

Pascal O. Zinn

2011

Griffith Harsh IV

Stephen Skirboll

2010

Andrew Parsa

Randy Jensen

2009

Tejas Sankar

Tal Shahar

2008

Raymond Sawaya

Not Given
2007

Christopher Nimsky

Not Given
2006

Ichiro Nakano

Not Given
2005

Walter Stummer

Not Given
2004

Justin Smith

Not Given
2003

John Sampson

Not Given

The Journal of Neuro-Oncology
Latest Newsletter

Upcoming Events

Share

Cafรฉpress Shop for the Tumor Section

tumor mug

Follow Us on Xโ€‹

Load More

Become a member of the Section on Tumors today.